SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017874
Filing Date
2023-05-04
Accepted
2023-05-04 16:16:02
Documents
51
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20230331.htm   iXBRL 10-Q 2144405
2 EX-10.1 alec-ex10_1.htm EX-10 95690
3 EX-31.1 alec-ex31_1.htm EX-31 29557
4 EX-31.2 alec-ex31_2.htm EX-31 29554
5 EX-32.1 alec-ex32_1.htm EX-32 11186
6 EX-32.2 alec-ex32_2.htm EX-32 11233
  Complete submission text file 0000950170-23-017874.txt   6255660

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20230331.xsd EX-101.SCH 31617
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alec-20230331_cal.xml EX-101.CAL 33342
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20230331_lab.xml EX-101.LAB 312986
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20230331_pre.xml EX-101.PRE 216166
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alec-20230331_def.xml EX-101.DEF 121517
45 EXTRACTED XBRL INSTANCE DOCUMENT alec-20230331_htm.xml XML 922377
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 23888964
SIC: 2836 Biological Products, (No Diagnostic Substances)